Pinnacle Financial Group, Inc.’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.43K Buy
+125
New +$4.88K ﹤0.01% 1816

Other funds holding TRAX

Pinnacle Financial Group, Inc.'s TRAX Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 125 shares worth $4.43K. The stake represents ﹤0.01% of the portfolio and ranks #1816 among its holdings.

180 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 125 shares of First Tracks Biotherapeutics worth $4.43K as of Q3 2026.
  • First Tracks Biotherapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • First Tracks Biotherapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1816 holding.
  • 180 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.